Plasminogen binding to cell surfaces

Fibrinolysis and Proteolysis

Volumn 12, Issue 4, 1998, Pages 183-189

  Felez J ^a,b  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b Institut de Recerca Oncologica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 0031735770     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(98)80012-X     Document Type: Review

References (54)

1. Miles L A, Dahlberg C M, Plow E F. The cell-binding domains of plasminogen and their function in plasma. J Biol Chem 1988; 263: 11928-11934.
2. Plow E F, Felez J, Miles L A. Cellular regulation of fibrinolysis. Thromb Haemost 1991; 66: 32-36.
3. Morse E E, Jackson D P, Conley C L. Role of platelet fibrinogen in the reactions of platelets to thrombin. J Clin Invest 1965; 44: 809-816.
4. Thorsen S, Brakman F, Astrup T. Influence of platelets fibrinolysis: a critical review. In: Ambrose J L (ed). Hematologic Reviews, vol 3. New York: Marcel Dekker, 1972; 123-179.
5. Miles L A, Plow E F. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260: 4303-4311.
6. Vassalli J-D, Baccino D, Belin D. A cellular binding site for the Mr 55 000 form of the human plasminogen activator, urokinase. J Cell Biol 1985; 100: 86-92.
7. Beebe D P. Binding of tissue plasminogen activator to human umbilical vein endothelial cells. Thromb Res 1987; 46: 241-254.
8. Hajjar K A, Harpel P C, Nachman R L. Binding of tissue plasminogen activator to cultured human endothelial cells. Circulation 1986; 74, Supp II: 233.
9. Hajjar K A, Harpel P C, Jaffe E A, Nachman R L. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261: 11656-11662.
10. Plow E F, Freaney D E, Plescia J, Miles L A. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986; 103: 2411-2420.
11. Boyle M D P, Lottenberg R. Plasminogen activation by invasive human pathogens. Thromb Haemost 1997; 77: 1-10.
12. Miles L A, Plow E F. Fibrinolysis and Cell Surfaces. London: Elsevier Science, 1987.
13. Miles L A. Regulation of fibrinolysis and proteolysis by plasminogen receptors. Biol Clin Hematol 1993; 15: 107-115.
14. Miles L A, Dahlberg C M, Levin E G, Plow E F. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 1989; 28: 9337-9343.
15. Christensen L, Clemmensen I. Differences in tetranectin immunoreactivity between bening and malignant breast tissue. Histochemistry 1991; 95: 427-433.
16. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as candidate plasminogen receptor. Biochemistry 1991; 30: 1682-1691.
17. Andronicos N M, Ranson M, Bognacki J, Baker M S. The human ENO1 gene product frecombinant human alpha-enolase) displays characteristics required for a plasminogen binding protein. Biochim Biophys Acta 1997; 1337: 27-39.
18. Hajjar K A, Guevara C A, Lev E, Dowling K, Chacko J. Interaction of the flbrinolytic receptor, annexin II, with the endothelial cell surface: essential role of endonexin repeat. J Biol Chem 1996; 271: 21652-21659.
19. Dudani A K, Ganz P R. Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein (a). Br J Haematol 1996; 95: 168-178.
20. Lopez-Alemany R, Correc P, Camoin L, Burtin P. Purification of the plasmin receptor from human carcinoma cells and comparison to alpha-enolase. Thromb Res 1994; 75: 371-381.
21. Redlitz A, Fowler B J, Plow E F, Miles L A. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995; 227: 407-415.
22. Gonzalez-Gronow M, Gawdi G, Pizzo S V. Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts. J Biol Chem 1994; 269: 4360-4366.
23. Hembrough T A, Kralovich K R, Gonias S L. Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation. Biochem J 1996; 317: 763-769.
24. Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 1991; 266: 16730-16735.
25. Merenmies J, Pihlaskari R, Laitinen J, Wartiovaara J, Rauvala H. 30-dDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. J Biol Chem 1991; 266: 16722-16729.
26. Kanalas J J, Makker S P. Identification of the rat Heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem 1991; 266: 10825-10829.
27. Fan Z, Larson PJ, Bognacki J, et al. Tissue factor regulates plasminogen binding and activation. Blood 1998; 91: 1987-1998.
28. Miles L A, Ginsberg M H, White J G, Plow E F. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-2009.
29. Hajjar K A, Jacovina A T, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191-21197
30. Cesarman G M, Guevara C A, Hajjar K A. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin mediated enhancement of t-PA dependent plasminogen activation. J Biol Chem 1994; 269: 21198-21203.
31. Dudani A K, Pluskota A, Ganz P R. Interaction of tissue plasminogen activator with a human endothelial cell 45-kilodalton plasminogen receptor. Biochem Cell Biol 1994; 72: 126-31.
32. Dudani A K, Cummings C, Hashemi S, Ganz P R. Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thromb Res 1993; 69: 185-196.
33. Dudani A K, Hashemi S, Aye M T, Ganz P R. Identification of an endothelial cell surface protein that binds plasminogen. Mol Cell Biochem 1991; 108: 133-140.
34. Lopez-Alemany R, Longstaff C, Fabregas P, Jardi M, Merton E, Felez J. Inhibition of plasmin generation on cell surfaces by monoclonal antibodies against a 55-60 kDa plasminogen receptor. Fibrinolysis 1996; 10: 5-A16 (Abstract).
35. Muesch A, Hartmann E, Rohde K, Rubartelli A, Sitia R, Rapoport T A. A novel pathway for secretory proteins? Trends Biochem Sci 1990; 15: 86-88.
36. Plow E F, Freaney D E, Plescia J, Miles L A. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. Cell Biol 1986; 106: 2411-2420.
37. Correc P, Fondanèche M-C, Bracke M, Burtin P. The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines. Int J Cancer 1990; 46: 745-750.
38. Wold F. Enolase. In: Boyer P D, editor. The Enzymes. 3rd ed. New York: Academic Press, 1971; 499-538.
39. Piatigorski J. Lens crystallins. Innovation associated with changes in gene regulation. J Biol Chem 1992; 174: 5204-5210.
40. McEver R P. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 1991; 45: 156-161.
41. Nakajima K, Nagata K, Hamanoue M, Takemoto N, Shimada A, Kohsaka S. Plasminogen-binding protein associated with the plasma membrane of cultured embryonic rat neocortical neurons. FEBS Lett 1993; 333: 223-228.
42. Hembrough T A, Vasudevan J, Allietta M M, Glass II W F, Gonias S L. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sci 1995; 108: 1071-82.
43. 2-macroglobulin. J Biol Chem 1991; 266: 12329-12336.
44. Felez J, Miles L A, Fabregas P, Jardi M, Plow E F, Lijnen H R. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells. Thromb Haemost 1996; 76: 577-585.
45. Ellis V. Functional analysis of the cellular receptor for urokinase in plasminogen activation. J Biol Chem 1996; 271: 14779-14784.
46. Felez J, Miles L A, Plescia J, Plow E F. Regulation of plasminogen receptors on human monocytes and monocytoid cells. J Cell Biol 1990; 111: 1673-1683.
47. Miles L A, Levin E G, Plescia J, Collen D, Plow E F. Plasminogen receptors, urokinase receptors and their modulation on human endothelial cells. Blood 1988; 72: 628-635.
48. Lu H, Mirshahi M, Krief P, Soria C, et al. Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells. Biochem Biophys Res Commun 1988; 155: 418-422.
49. Jardi M, Lopez-Alemany R, Arza B, Rodriguez-Lambies N, Miles L A, Felez J. Functional consequences of the up-modulation of plasminogen receptors on leukocytes. 5th International Annual European Vascular Biology Association 1998:D-1 (Abstract).
50. Burtin P, Fondaneche M. Receptor for plasmin on human carcinoma cells. J Natl Cancer Inst 1988; 80: 762-765.
51. Schleef R R, Loskutoff D J. Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors. Haemostasis 1988; 18: 328-341.
52. Broder C C, Lottenberg R, Von Mering G O, Johnston KH, Boyle MDP. Isolation of a prokaryotic plasmin receptor. Relationship to a plasminogen activator produced by the same microorganism. J Biol Chem 1991; 266: 4922-4928.
53. Felez J, Chanquia CJ, Fabregas P, Plow E F, Miles L A. Competition between plasminogen and t-PA for cellular binding sites. Blood 1993; 82: 2433-2441.
54. Hoylaerts M, Rijken D C, Lijnen H R, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem 1982; 257: 2912-2919.